About
Science
Bioprocesses for production of
antibodies; therapeutic proteins; recombinant, subunit, conjugate, viral and DNA/mRNA vaccines;
gene therapies; and secondary metabolites
Strategy
Science-based risk assessment, process understanding / characterization, and control strategy
Quality-by-design and knowledge management
Execution
Early development at the interface with discovery
Late development at the interface with commercial production including lifecycle management
Copyright © 2020 BioProcess Advantage LLC - All Rights Reserved.
Powered by GoDaddy Website Builder